subject area of
- A PET study of effects of chronic 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) on serotonin markers in Göttingen minipig brain Journal Articles
- A Step Change in Oral Anticoagulation: Lack of Coagulation Monitoring with Ximelagatran Journal Articles
- A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I Journal Articles
- A review of the oral direct thrombin inhibitor ximelagatran Journal Articles
- Acute reversal of anticoagulant-induced bleeding complications. Journal Articles
- Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Journal Articles
- Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Journal Articles
- Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer Journal Articles
- Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Journal Articles
- Beyond Unfractionated Heparin and Warfarin Journal Articles
- Clinical trials of new anticoagulants. Journal Articles
- Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin Journal Articles
- Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation Journal Articles
- Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteers Journal Articles
- Effects of PKB/Akt inhibitors on insulin-stimulated lipogenesis and phosphorylation state of lipogenic enzymes in white adipose tissue Journal Articles
- Hormone-sensitive lipase activity and triacylglycerol hydrolysis are decreased in rat soleus muscle by cyclopiazonic acid Journal Articles
- Inhibition of Microsurgical Thrombosis by the Platelet Glycoprotein IIb/IIIa Antagonist SR121566A Journal Articles
- New Anticoagulants for Treatment of Venous Thromboembolism Journal Articles
- New anticoagulants Conferences
- Nonbleeding complications of unfractionated and low-molecular weight heparins. Journal Articles
- Orally Active Direct Thrombin Inhibitors Journal Articles
- Pharmacokinetics of ximelagatran and relationship to clinical response in acute deep vein thrombosis Journal Articles
- Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD Journal Articles
- Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents Journal Articles
- Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran Journal Articles
- Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long‐term secondary prevention of venous thromboembolism Journal Articles
- Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism Journal Articles
- Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran Journal Articles
- The Role of Ximelagatran in the Treatment of Venous Thromboembolism Journal Articles
- The beginning of the end of warfarin? Journal Articles
- The benefit-to-risk profile of melagatran is superior to that of hirudin in a rabbit arterial thrombosis prevention and bleeding model Journal Articles
- Ximelagatran for Secondary Prevention of Venous Thromboembolism Journal Articles
- Ximelagatran for the secondary prevention of venous thromboembolism Journal Articles
- Ximelagatran in the Clinic: Practical Management of Patients Journal Articles
- Ximelagatran or Warfarin for Stroke Prevention in Patients With Atrial Fibrillation? Journal Articles
- Ximelagatran or warfarin in atrial fibrillation? Journal Articles
- Ximelagatran: the first oral direct thrombin inhibitor Journal Articles
- Ximelagatran: the first oral direct thrombin inhibitor. Journal Articles